PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17203757-13 2006 CONCLUSION: The Caelyx-TNFalpha combination was proven to increase the efficacy of Caelyx alone, with a very low toxicity. liposomal doxorubicin 16-22 tumor necrosis factor Homo sapiens 23-31 35562182-7 2022 Multiple cycles of intravenous c-JO4 plus Doxil (four cycles, 4 weeks apart, simulating the treatment regimen in the clinical trial) elicited antibodies against c-JO4 that increased with each cycle and were accompanied by elevation of pro-inflammatory cytokines IL-6 and TNFalpha. liposomal doxorubicin 42-47 tumor necrosis factor Homo sapiens 271-279